Skip to content

A Study to Assess an Ayurvedic Medicine (Tryushnadi Guggulu) for High Lipid Levels in Blood

RANDOMISED CONTROLLED CLINICAL STUDY OF TRYUSHNADIGUGGULU IN THE MANAGEMENT OF DYSLIPIDEMIA. - NILL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102395
Enrollment
80
Registered
2026-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

DR PRADEEP SAINI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients who will agree for giving consent after making aware of the merits/demerits of the trial. 2 Patient full fil at least one criteria for dyslipidemia as explain in diagnostic criteria 3 Patient Agreed for investigations (if needed) before inclusion into the trial and after completion of trial and follow up for assessment and clinical evaluation. Patient full fill at least one criteria for Dyslipidemia as explain in diagnostic criteria

Exclusion criteria

Exclusion criteria: 1 Participants suffering from major systemic disorders like cardiac diseases (IHD), IDDM, uncontrolled Hypertension, Hyperthyroid, Renal and Hepatic diseases etc 2 Not agreed for giving consent / investigations / follow up

Design outcomes

Primary

MeasureTime frame
Primary outcome will be assessed by comparing the change from baseline to end of treatment between the Tryushnadi Guggulu and the Atorvastatin.Timepoint: 60 days

Secondary

MeasureTime frame
NillTimepoint: Nill

Countries

India

Contacts

Public ContactProf Dr Anil Sharma

Faculty of Indian Medical System SGT University Gurugram Haryana

anilherbals@gmail.com9416085092

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026